• Skip to main content
  • Main Menu
  • Navigation for access to support pages
  • Navigation for access to legal pages
 Logo Viva Technology
  • Session Recordings
  • Speakers
  • Exhibitors
  • FAQ
  • General Public Day
  • confirmation_numberGet Your 2026 Pass
  • Become an Exhibitor
 Viva Technology

17-20 June 2026

Paris Expo Porte de Versailles

1 Place de la Porte de Versailles

F-75015 Paris France

More Infoarrow_right_alt

Event organizers

2025 ThemesConference ProgramOur Speakers

Exhibitors at VivaTech2025 Partners

Startups at VivaTechInvestors at VivaTech2025 Startup Challenges and Awards

JournalistsMedia Partners2025 PresskitPress Releases

About UsOur CommitmentsGeneral Public DayPractical Information

©Viva Technology 2016-2025 all rights reserved

Site MapSite noticeWebsite terms & conditionsB2B terms & conditionsData Privacy
  1.  Logo Viva Technology
  2. Speakers
  3. Jay Gambetta
 Photo Jay Gambetta

Jay Gambetta

IBM Fellow and VP of IBM Quantum

IBM

#
Deep Tech & Quantum Computing

About Me

Dr. Jay Gambetta is the Vice President in charge of IBM’s overall Quantum initiative, and an IBM Fellow in recognition of his leadership in advancing superconducting quantum computing and establishing IBM’s quantum strategy to bring quantum computing to the world, and to make the world quantum safe. Under his leadership, IBM has grown to become the predominant quantum service utilized by 649,000+ users, including 280+ members of the IBM Quantum Network, to run over 3 trillion quantum circuits. To date, IBM Quantum has deployed over 80 quantum systems online, building the foundations of the quantum industry. In addition, he was responsible for the creation and early development of Qiskit; the leading open-source quantum computing software development kit.

Hear My Insights

Quantum Computing: What Leaders Need To Know

Quantum technology taps into the unusual behavior of atomic and sub-atomic particles to perform far more complex calculations than today’s computers. The hope is that this could lead to breakthroughs in drug discovery and previously unsolvable problems as well as solutions that have the potential to generate higher returns for business. How should business leaders be preparing for this monumental market shift?